GTSE1 and neoplasm: Zheng et al. (18) suggest that knocking down GTSE1 leads to dysregulation of mitotic S phase in tumor cells, disrupting the cell cycle and promoting tumor cell apoptosis, which may explain the better prognosis in patients with low GTSE1 expression.